COMPPARE Newsletter: Summer 2023


Dr. Nancy Mendenhall

A Message from Dr. Nancy Mendenhall

Since COMPPARE was launched in 2017, new information has emerged that suggests there may be other differences in outcomes between photon and proton radiation in prostate cancer. We would like to answer as many of these questions as possible and preliminary patient surveys sent to our COMPPARE proton and photon cohorts in June will assist our team in this process. Read Dr. Mendenhall’s message.




ProCure, New Jerseey Partner Site Spotlight: The ProCure Proton Therapy Center

ProCure Proton Therapy Center opened its doors in Somerset NJ in March 2012, becoming the tri-state region’s first and longest-established proton therapy facility. Eight years later, in October 2020, the center marked another milestone: a prostate cancer patient became the 5,000th person treated with proton therapy at ProCure. The center is also a dedicated COMPPARE partner site that has diligently recruited and retained prostate cancer patients for the study. Follow the conversation here.



Dan McCarthy's prostate cancer journeyScreening, Support, and Seizing the Moment: Dan McCarthy’s Journey to New Beginnings

Seven years ago, a routine physical for Dan McCarthy yielded an unexpected and unwelcome result: an elevated PSA and a recommendation for a biopsy. Dan and his wife Cindy O’Connell couldn’t have been more shocked when the results were positive for prostate cancer. “There is no family history of cancer, and while I’ve had other health problems, I did not think the ‘C word’ would be part of my life,” Dan recalled.  Read more about Dan McCarthy’s journey.



Participate in COMPPARE's new survey

Surveys Will Assist in Designing the Next Phase of COMPPARE

In early June, COMPPARE Coordinators administered over 500 surveys to participants. Their purpose is to guide the design of the next grant proposal to secure funding to follow COMPPARE patients another five years. More participants will receive surveys in the coming weeks – learn why your participation matters.




Research reported in this newsletter was partially funded through a Patient-Centered Outcomes Research Institute (PCORI) Award (PCS-2017C1-0422). The views, statements, and opinions presented in this newsletter are solely the responsibility of the authors and do not necessarily represent the views of PCORI, its Board of Governors, or Methodology Committee.


We look forward to sharing our patient-centric news with you. Below you can find an archive of our issues and subscribe to receive COMPPARE Connection in your inbox.


COMPPARE Newsletter Subscription